Insmed Inc Drug Patent Portfolio
Insmed Inc's Family Patents
Clinical Trials
Recent Clinical Trials by Insmed Inc:
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Normal Hepatic Function and Participants With Hepatic Impairment | Insmed Incorporated | NA |
RECRUITING
(Sep 1, 2026)
| PHASE1 |
| A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension | Insmed Incorporated | NA |
COMPLETED
(Mar 1, 2026)
| PHASE2 |
| A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS) | Insmed Incorporated | NA |
ACTIVE NOT RECRUITING
(Mar 1, 2026)
| PHASE2 |
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List